Fang WJ - Search Results

1

Characteristic CYP2A6 genetic polymorphisms detected by TA cloning-based sequencing in Chinese digestive system cancer patients with S-1 based chemotherapy.

Fang WJ, Mou HB, Jin DZ, Zheng YL, Zhao P, Mao CY, Peng L, Huang MZ, Xu N. Fang WJ, et al. Oncol Rep. 2012 May;27(5):1606-10. doi: 10.3892/or.2012.1678. Epub 2012 Feb 7. Oncol Rep. 2012. PMID: 22322240

2

Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer.

Xu N, Shen P, Zhang XC, Yu LF, Bao HY, Shi GM, Huang S, Chen J, Mou HB, Fang WJ. Xu N, et al. Among authors: fang wj. Cancer Chemother Pharmacol. 2007 Jan;59(1):1-7. doi: 10.1007/s00280-006-0237-2. Epub 2006 Apr 14. Cancer Chemother Pharmacol. 2007. PMID: 16614849 Clinical Trial.

3

A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium.

Xu N, Zhang XC, Xiong JP, Fang WJ, Yu LF, Qian J, Zhang L. Xu N, et al. Among authors: fang wj. BMC Cancer. 2007 Jun 9;7:98. doi: 10.1186/1471-2407-7-98. BMC Cancer. 2007. PMID: 17559681 Free PMC article. Clinical Trial.

4

A Phase II trial of oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX4) as first-line chemotherapy in advanced colorectal cancer: a China single-center experience.

Xu N, Fang WJ, Zhang XC, Yu LF, Bao HY, Shi GM, Huang S, Shen P. Xu N, et al. Among authors: fang wj. Cancer Invest. 2007;25(7):599-605. doi: 10.1080/07357900701470739. Cancer Invest. 2007. PMID: 17882631 Clinical Trial.

5

Detection of let-7a microRNA by real-time PCR in colorectal cancer: a single-centre experience from China.

Fang WJ, Lin CZ, Zhang HH, Qian J, Zhong L, Xu N. Fang WJ, et al. J Int Med Res. 2007 Sep-Oct;35(5):716-23. doi: 10.1177/147323000703500518. J Int Med Res. 2007. PMID: 17944059 Free article.

6

Phase II study of FOLFIRI regimen in patients with advanced colorectal cancer refractory to fluoropyrimidine and oxaliplatin.

Bao HY, Fang WJ, Zhang XC, Shi GM, Huang S, Yu LF, Chen J, Mou HB, Deng J, Shen P, Xu N. Bao HY, et al. Among authors: fang wj. Cancer Chemother Pharmacol. 2011 Jan;67(1):147-52. doi: 10.1007/s00280-010-1301-5. Epub 2010 Mar 11. Cancer Chemother Pharmacol. 2011. PMID: 20221830 Clinical Trial.

7

Phase II trial of gefitinib in pretreated Chinese women with advanced non-small-cell lung cancer.

Deng J, Fang WJ, Zhang XC, Wu DP, Fang HM, Chen J, Qian J, Mou HB, Chu BB, Xu N, Teng LS. Deng J, et al. Among authors: fang wj, fang hm. Med Oncol. 2012 Jun;29(2):595-9. doi: 10.1007/s12032-011-9891-2. Epub 2011 Mar 12. Med Oncol. 2012. PMID: 21399997 Clinical Trial.

8

Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways.

Mou H, Zheng Y, Zhao P, Bao H, Fang W, Xu N. Mou H, et al. Toxicol In Vitro. 2011 Aug;25(5):1027-32. doi: 10.1016/j.tiv.2011.03.023. Epub 2011 Apr 3. Toxicol In Vitro. 2011. PMID: 21466843

9

Rapid molecular identification of Listeria species by use of real-time PCR and high-resolution melting analysis.

Jin D, Luo Y, Zhang Z, Fang W, Ye J, Wu F, Ding G. Jin D, et al. FEMS Microbiol Lett. 2012 May;330(1):72-80. doi: 10.1111/j.1574-6968.2012.02535.x. Epub 2012 Mar 15. FEMS Microbiol Lett. 2012. PMID: 22372942

10

Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis.

Peng L, Zhan P, Zhou Y, Fang W, Zhao P, Zheng Y, Xu N. Peng L, et al. Mol Biol Rep. 2012 Oct;39(10):9473-84. doi: 10.1007/s11033-012-1812-8. Epub 2012 Jun 23. Mol Biol Rep. 2012. PMID: 22729879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters